About the Project
ULISES develops a disruptive, immunologic-based treatment strategy where cancer cells are reprogrammed to become “visible” to the patients’ immune system.
This breakthrough therapy will offer several advantages over current therapies: much greater efficiency; use of the patient’s own immune system to attack the cancerous cells; and fewer side effects meaning improved patient outcomes.
![](https://www.icons.it/wp-content/uploads/2021/02/Reference-logo_ULISES.png)
Our role
We are responsible for the design, coordination and implementation of communication and dissemination activities.
ICONS is also in charge of defining the exploitation strategy and planning.